scispace - formally typeset
R

Roland E. Schmieder

Researcher at University of Erlangen-Nuremberg

Publications -  780
Citations -  85811

Roland E. Schmieder is an academic researcher from University of Erlangen-Nuremberg. The author has contributed to research in topics: Blood pressure & Essential hypertension. The author has an hindex of 97, co-authored 717 publications receiving 78138 citations. Previous affiliations of Roland E. Schmieder include Complutense University of Madrid & University of Regensburg.

Papers
More filters
Journal ArticleDOI

Improved classification of dippers by individualized analysis of ambulatory blood pressure profiles

Christoph D. Gatzka, +1 more
- 01 Jul 1995 - 
TL;DR: Investigation of ambulatory blood pressure profiles according to the patients' individual reported awake/sleep pattern resulted in a better classification of dippers and nondippers, since misclassifications due to divergent sleep patterns were avoided.
Journal ArticleDOI

Left Ventricular Hypertrophy and its Regression: Pathophysiology and Therapeutic Approach Focus on Treatment by Antihypertensive Agents

Markus P. Schlaich, +1 more
- 01 Nov 1998 - 
TL;DR: In this article, the authors found that angiotensin converting enzyme (ACE) inhibitors reduced LVM by 12% (95% CI, 9.0-14.5%) and calcium channel blockers by 11% with diuretics in the intermediate range, with the role of new antihypertensive agents such as AT-receptor antagonists cannot be conclusively answered.
Journal ArticleDOI

Measurement of kidney perfusion by magnetic resonance imaging: comparison of MRI with arterial spin labeling to para-aminohippuric acid plasma clearance in male subjects with metabolic syndrome.

Martin Ritt, +7 more
- 01 Apr 2010 - 
TL;DR: Perfusion measurement of a single coronal kidney slice by MRI-ASL is able to approximate kidney perfusions and to approximate changes in kidney perfusion due to pharmacological intervention.
Journal ArticleDOI

Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension.

Alberto Zanchetti, +9 more
- 01 Apr 2009 - 
TL;DR: It is concluded that their complex design precludes a simple interpretation, that several important questions remain unanswered and that direct evidence – particularly in support of lowering systolic BP below 140 or 130 mmHg – is urgently needed.
Journal ArticleDOI

European Society of Hypertension position paper on renal denervation 2021.

Roland E. Schmieder, +15 more
- 01 Sep 2021 - 
TL;DR: The ESH Position Paper 2021 with updated proposed recommendations was deemed necessary after the publication of a set of new pivotal sham-controlled randomized clinical trials (RCTs), which provided important information about the efficacy and safety of endovascular device-based renal denervation (RDN) for hypertension treatment as discussed by the authors.